Tixagevimab/Cilgavimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tixagevimab/Cilgavimab, covering 2023-08-08 to 2023-08-08. Get the full timeline:
Most recent: Clinical Trial Update: Study of Tixagevimab/Cilgavimab and Regdanvimab Efficacy for Treatment of COVID-19 [Phase 4]